The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118668164 11866816 4 F 201203 20160714 20151224 20160720 EXP US-ASTRAZENECA-2012SE74430 ASTRAZENECA 707.00 MON F Y 71.20000 KG 20160720 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118668164 11866816 1 PS CRESTOR ROSUVASTATIN CALCIUM 1 Oral U U 21366 TABLET
118668164 11866816 2 SS CRESTOR ROSUVASTATIN CALCIUM 1 Oral U U 21366 40 MG TABLET QD
118668164 11866816 3 C SIMVASTATIN. SIMVASTATIN 1 TAKE ONE TABLET BY MOUTH 0 TABLET
118668164 11866816 4 C METFORMIN METFORMIN HYDROCHLORIDE 1 500.0MG UNKNOWN 0 500 MG
118668164 11866816 5 C LANCET 2 0
118668164 11866816 6 C OMEPRAZOLE. OMEPRAZOLE 1 0
118668164 11866816 7 C ASPIRIN. ASPIRIN 1 0
118668164 11866816 8 C PROPRANOLOL PROPRANOLOLPROPRANOLOL HYDROCHLORIDE 1 0
118668164 11866816 9 C GABAPENTIN. GABAPENTIN 1 0
118668164 11866816 10 C BENAZEPRIL BENAZEPRIL HYDROCHLORIDE 1 0
118668164 11866816 11 C LORATADINE. LORATADINE 1 0
118668164 11866816 12 C RANITIDINE. RANITIDINE 1 0
118668164 11866816 13 C MECLIZINE MECLIZINE HYDROCHLORIDE 1 0
118668164 11866816 14 C NAPROXEN. NAPROXEN 1 0
118668164 11866816 15 C TOBRAMYCIN. TOBRAMYCIN 1 0
118668164 11866816 16 C AZITHROMYCIN ANHYDROUS. AZITHROMYCIN ANHYDROUS 1 0
118668164 11866816 17 C ACTONEL RISEDRONATE SODIUM 1 0
118668164 11866816 18 C FAMOTIDINE. FAMOTIDINE 1 0
118668164 11866816 19 C DEXILANT DEXLANSOPRAZOLE 1 0
118668164 11866816 20 C NIASPAN NIACIN 1 0
118668164 11866816 21 C DIFLUCAN FLUCONAZOLE 1 0
118668164 11866816 22 C FOSAMAX ALENDRONATE SODIUM 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118668164 11866816 1 Blood cholesterol increased
118668164 11866816 2 Blood cholesterol increased

Outcome of event

Event ID CASEID OUTC COD
118668164 11866816 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
118668164 11866816 Diabetic neuropathy
118668164 11866816 Hypertension
118668164 11866816 Rhabdomyolysis
118668164 11866816 Type 2 diabetes mellitus

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
118668164 11866816 1 20080801 0
118668164 11866816 2 20100628 0
118668164 11866816 3 201203 0
118668164 11866816 6 2008 0
118668164 11866816 7 2008 0
118668164 11866816 8 2008 0
118668164 11866816 9 2008 0
118668164 11866816 10 2008 0
118668164 11866816 11 2008 0
118668164 11866816 12 2008 0
118668164 11866816 13 2008 0
118668164 11866816 14 2009 0
118668164 11866816 15 2009 0
118668164 11866816 16 2009 0
118668164 11866816 17 2009 0
118668164 11866816 18 2009 0
118668164 11866816 19 2009 0
118668164 11866816 20 2009 0
118668164 11866816 21 2009 0